The results of our study corroborate the previous findings of Zhong et al., who observed high COL6A2 expression correlated with poor prognosis in metastatic ccRCC, based on 3 additional GEO datasets (GSE85258, GSE105288, and GSE22541) 28. This evidence concerns the gene COL6A2 and nonpapillary renal cell carcinoma.